SmPC - Accofil 12 MU/0.2 ml solution for injection or infusion in pre-filled syringe: Change history
View Summary of Product Characteristics (SmPC - Accofil 12 MU/0.2 ml solution for injection or infusion in pre-filled syringe)
Last updated on this site: 02 Aug 2023
To update sections 2, 3, 4.2, 4.4, 4.6, 4.8, 5.1, 5.2, 5.3, 6.2, 6.6 of the SmPC and PIL, in line with the reference product information Neupogen, Singleject 30 MU (0.6 mg/mL) & 48 MU (0.96 mg/mL) solution for injection in a pre-filled syringe) by MAH Amgen Europe B.V. PL 16216/0043.
View Summary of Product Characteristics (SmPC - Accofil 12 MU/0.2 ml solution for injection or infusion in pre-filled syringe)
Last updated on this site: 02 Aug 2023
To update sections 2, 3, 4.2, 4.4, 4.6, 4.8, 5.1, 5.2, 5.3, 6.2, 6.6 of the SmPC and PIL, in line with the reference product information Neupogen, Singleject 30 MU (0.6 mg/mL) & 48 MU (0.96 mg/mL) solution for injection in a pre-filled syringe) by MAH Amgen Europe B.V. PL 16216/0043.
-
Changes: (Updated: 02 Aug 2023)
To update sections 2, 3, 4.2, 4.4, 4.6, 4.8, 5.1, 5.2, 5.3, 6.2, 6.6 of the SmPC and PIL, in line with the reference product information Neupogen, Singleject 30 MU (0.6 mg/mL) & 48 MU (0.96 mg/mL) solution for injection in a pre-filled syringe) by MAH Amgen Europe B.V. PL 16216/0043.
-
Changes: (Updated: 21 Oct 2022)
Update
-
Changes: (Updated: 21 Sep 2022)
Initial upload